OYST

Oyster Point Pharma, Inc. Common Stock
OYST

Overview Fund Activity
Delisted

OYST was delisted on the 30th of December, 2022.

Back to rankings

66 hedge funds and large institutions have $380M invested in Oyster Point Pharma, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
-6
Holders Change %
-8.33%
% of All Funds
1.34%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
7
Increased
21
Reduced
20
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GKIM
GW&K Investment Management
Massachusetts
+$2.69M
2
SCM
Sio Capital Management
New York
+$2.23M
3
BlackRock
BlackRock
New York
+$1.43M
4
EA
Emerald Advisers
Pennsylvania
+$1.38M
5
Charles Schwab
Charles Schwab
California
+$1.14M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$10.9M
2
MICM
Matthews International Capital Management
California
-$6.5M
3
GPP
Great Point Partners
Connecticut
-$3.05M
4
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
-$1.89M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.56M
Name Holding Trade Value Shares
Change 		Shares
Change %
CBA
76
Coastal Bridge Advisors
Connecticut
– -$210K -7,260 Closed
FMT
77
First Mercantile Trust
Tennessee
– -$81K -2,798 Closed
PSC
78
Piper Sandler & Co
Minnesota
– -$14K -500 Closed
FWM
79
Filbrandt Wealth Management
Wisconsin
– -$3K -100 Closed
1 2 3
4